glp-1 for bulimia GLP1-RA and Pediatric Populations: Psychosocial Issues and Eating Disorder Treatment Approaches Co-Morbid Obesity and Eating Disorders | Current Pediatrics Reports Do Weight Loss Drugs Like

Keeping track of your calories

Private clinics offering lipotropic injections should be approached with caution, and patients should verify that practitioners are appropriately qualified and that products meet regulatory standards

Even fewer will need surgery

van Dalfsen JH, Markus CR

Taken together, the figure highlights a key mechanistic principle underlying the therapeutic rationale for multi-agonist strategies: while GLP-1R monotherapy achieves meaningful metabolic and hepatic benefits exclusively through indirect, systemic pathways, the addition of GIPR and - most importantly - GCGR co-agonism introduces complementary and increasingly direct hepatic mechanisms, providing the pharmacological basis for the superior efficacy observed with dual and triple agonists in MASLD/MASH